A newly published report by Coherent Market Insights reveals a sustainable growth in opportunities in the personalized medicine biomarkers market. Coherent Market Insights’ analyst projected the personalized medicine biomarkers market to be valued at US$ 68.11 Bn in 2031. It is expected to exhibit a CAGR of 15.6% over the forecast period 2024-2031. Market Dynamics: Rising disease Read More…
